Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 211Triple Negative Breast Neoplasms 32Inflammatory Breast Neoplasms 21Breast Neoplasms, Male 5Primary Breast Cancer 3Neoplasms 3Carcinoma, Ductal, Breast 3Pathologic Complete Response 2HER2-negative Breast Cancer 2Cardiotoxicity 2Breast Diseases 2Women With Primary Breast Cancer 1Unilateral HER2 Positive Breast Cancer 1Sarcoma 1Resectable HER2-positive Breast Cancer 1Postoperative Complications 1Patient Acceptance of Health Care 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neutropenia 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Neoadjuvant Operable Breast Cancer 1Kenny-Caffey syndrome, Type 1 1Hormone Receptor Positive HER-2 Negative Breast Cancer 1Her2-Positive Breast Cancer 1HR-positive,HER2-negative Breast Cancer 1HR+/HER2- Breast Cancer 1HER2-negative Early Breast Cancer 1HER2 Positive Early Breast Cancer 1

Interventions

Zoledronic Acid 1Trastuzumab 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Micrometastasis × Epirubicin × Breast × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡